- Home
- PRGO vs AAPG Comparison
PRGO vs AAPG Comparison
Compare PRGO & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- AAPG
- Stock Information
- Founded
- PRGO 1887
- AAPG 2009
- Country
- PRGO Ireland
- AAPG China
- Employees
- PRGO N/A
- AAPG N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- PRGO Health Care
- AAPG Health Care
- Exchange
- PRGO Nasdaq
- AAPG Nasdaq
- Market Cap
- PRGO 3.1B
- AAPG 3.6B
- IPO Year
- PRGO 1991
- AAPG 2025
- Fundamental
- Price
- PRGO $21.13
- AAPG $38.95
- Analyst Decision
- PRGO Buy
- AAPG Buy
- Analyst Count
- PRGO 4
- AAPG 1
- Target Price
- PRGO $33.00
- AAPG N/A
- AVG Volume (30 Days)
- PRGO 1.5M
- AAPG 11.3K
- Earning Date
- PRGO 11-05-2025
- AAPG 11-06-2025
- Dividend Yield
- PRGO 5.45%
- AAPG N/A
- EPS Growth
- PRGO N/A
- AAPG N/A
- EPS
- PRGO N/A
- AAPG N/A
- Revenue
- PRGO $4,326,100,000.00
- AAPG $54,524,554.00
- Revenue This Year
- PRGO $2.28
- AAPG N/A
- Revenue Next Year
- PRGO $0.54
- AAPG $387.72
- P/E Ratio
- PRGO N/A
- AAPG N/A
- Revenue Growth
- PRGO N/A
- AAPG N/A
- 52 Week Low
- PRGO $21.03
- AAPG $16.50
- 52 Week High
- PRGO $30.93
- AAPG $48.45
- Technical
- Relative Strength Index (RSI)
- PRGO 27.65
- AAPG N/A
- Support Level
- PRGO $22.00
- AAPG N/A
- Resistance Level
- PRGO $22.58
- AAPG N/A
- Average True Range (ATR)
- PRGO 0.54
- AAPG 0.00
- MACD
- PRGO -0.09
- AAPG 0.00
- Stochastic Oscillator
- PRGO 3.39
- AAPG 0.00
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.